Christopher G Kevil Selected Research

Sodium Nitrite

2/2014	Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: safety, walking distance and endothelial function.
12/2012	Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension.
7/2012	Nitrite anion stimulates ischemic arteriogenesis involving NO metabolism.
7/2012	Single-dose pharmacokinetics of different oral sodium nitrite formulations in diabetes patients.
2/2010	Genome expression profiling and network analysis of nitrite therapy during chronic ischemia: possible mechanisms and interesting molecules.
5/2008	Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis.
5/2005	Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher G Kevil Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 03/2004
14	Ischemia 01/2020 - 05/2005
11	Colitis 01/2020 - 02/2006
10	Hypoxia (Hypoxemia) 01/2021 - 05/2005
10	Inflammation (Inflammations) 01/2018 - 02/2006
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2013
7	Vascular Remodeling 01/2020 - 07/2012
5	Peripheral Arterial Disease 02/2014 - 05/2008
4	Atherosclerosis 01/2022 - 05/2012
4	Carcinogenesis 10/2021 - 02/2011
4	Reperfusion Injury 02/2015 - 05/2008
3	Fibrosis (Cirrhosis) 01/2022 - 01/2018
3	Hypertension (High Blood Pressure) 01/2021 - 12/2012
3	Cardiomyopathies (Cardiomyopathy) 12/2020 - 01/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 12/2020 - 01/2019
3	Pathologic Processes 10/2020 - 08/2011
3	Pathologic Neovascularization 01/2020 - 02/2009
3	Hyperglycemia 01/2018 - 01/2011
3	Diabetes Mellitus 02/2014 - 01/2012
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2013 - 12/2004
3	Infarction (Infarctions) 08/2009 - 12/2004
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 01/2019
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 09/2021 - 11/2018
2	Thyroid Neoplasms (Thyroid Cancer) 09/2021 - 11/2018
2	Brain Injuries (Brain Injury) 01/2021 - 12/2004
2	Genomic Instability 01/2021 - 01/2019
2	Heart Failure 12/2020 - 09/2013
2	Vascular Diseases (Vascular Disease) 10/2020 - 10/2013
2	Hyperhomocysteinemia 10/2020 - 01/2018
2	Arteriovenous Fistula 12/2019 - 10/2019
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 08/2017
2	Necrosis 01/2014 - 05/2005
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2011 - 04/2006
2	Myocardial Infarction 08/2009 - 05/2005
2	Chronic Limb-Threatening Ischemia 05/2008 - 09/2007
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Ataxia (Dyssynergia) 01/2022
1	Telangiectasis (Telangiectasia) 01/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Systolic Heart Failure 01/2022

Drug/Important Bio-Agent (IBA)

17	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 09/2007
16	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2021 - 10/2012
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2009
13	NitritesIBA 01/2018 - 05/2005
8	Sulfides (Thioethers)IBA 01/2022 - 08/2017
8	EnzymesIBA 11/2021 - 10/2016
7	Sodium NitriteIBA 02/2014 - 05/2005
6	Dextrans (Dextran)FDA Link 01/2020 - 04/2006
6	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 04/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 04/2006
4	AntioxidantsIBA 01/2022 - 01/2011
4	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2007
4	LipidsIBA 01/2022 - 02/2009
4	CystathionineIBA 01/2020 - 01/2015
4	LyasesIBA 01/2020 - 01/2015
4	Peptides (Polypeptides)IBA 01/2018 - 02/2009
4	AnionsIBA 01/2014 - 02/2011
3	Oxygen (Dioxygen)IBA 01/2021 - 09/2012
3	GasotransmittersIBA 01/2021 - 03/2015
3	Biological ProductsIBA 11/2016 - 01/2011
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2015 - 06/2007
3	ProdrugsIBA 01/2014 - 02/2011
3	Protein Isoforms (Isoforms)IBA 09/2013 - 07/2011
3	Dipyridamole (Persantine)FDA LinkGeneric 01/2011 - 03/2010
3	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 02/2006 - 08/2004
2	Superoxides (Superoxide)IBA 01/2022 - 10/2013
2	Pharmaceutical PreparationsIBA 01/2022 - 09/2014
2	Apolipoproteins E (ApoE)IBA 01/2022 - 08/2017
2	CollagenIBA 01/2022 - 08/2017
2	IronIBA 01/2022 - 05/2005
2	polysulfideIBA 10/2021 - 01/2020
2	Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA 09/2021 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 10/2013
2	Dynamins (Dynamin)IBA 12/2020 - 01/2020
2	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2020 - 01/2019
2	Caveolin 1IBA 01/2020 - 02/2009
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2019 - 10/2019
2	SulfurIBA 01/2018 - 10/2016
2	CytokinesIBA 01/2015 - 02/2006
2	NitratesIBA 01/2014 - 12/2009
2	ChemokinesIBA 08/2012 - 01/2008
2	S-NitrosothiolsIBA 10/2010 - 05/2005
2	Recombinases (Recombinase)IBA 06/2007 - 02/2006
2	IntegrinsIBA 04/2006 - 12/2004
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022
1	ApolipoproteinsIBA 01/2022
1	Ataxia Telangiectasia Mutated ProteinsIBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	AmphetaminesIBA 01/2022
1	AcidsIBA 01/2022

Therapy/Procedure

16	Therapeutics 11/2021 - 03/2004
4	Ligation 01/2020 - 07/2012
3	Drug Therapy (Chemotherapy) 09/2021 - 11/2018
2	Transplantation 11/2021 - 05/2005
1	Defibrillators (Defibrillator) 01/2022
1	Secondary Prevention 01/2022
1	Muscle Denervation 01/2022